Orbimed Advisors LLC Thermo Fisher Scientific Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 84,400 shares of TMO stock, worth $43.3 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
84,400
Previous 132,000 36.06%
Holding current value
$43.3 Million
Previous $73 Million 28.49%
% of portfolio
1.23%
Previous 1.76%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$531.86 - $624.21 $25.3 Million - $29.7 Million
-47,600 Reduced 36.06%
84,400 $52.2 Million
Q1 2024

May 15, 2024
SELL
$528.82 - $599.43 $6.24 Million - $7.07 Million
-11,800 Reduced 8.21%
132,000 $76.7 Million
Q3 2023

Nov 14, 2023
SELL
$498.29 - $574.41 $9.47 Million - $10.9 Million
-19,000 Reduced 11.67%
143,800 $72.8 Million
Q2 2023

Aug 14, 2023
BUY
$508.46 - $591.13 $7.63 Million - $8.87 Million
15,000 Added 10.15%
162,800 $84.9 Million
Q1 2023

May 15, 2023
SELL
$535.0 - $604.82 $29.1 Million - $32.9 Million
-54,400 Reduced 26.9%
147,800 $85.2 Million
Q3 2022

Nov 14, 2022
BUY
$507.19 - $604.49 $45 Million - $53.7 Million
88,800 Added 78.31%
202,200 $103 Million
Q2 2022

Aug 15, 2022
SELL
$500.9 - $612.21 $3.61 Million - $4.41 Million
-7,200 Reduced 5.97%
113,400 $61.6 Million
Q1 2022

May 16, 2022
BUY
$524.0 - $644.92 $13.6 Million - $16.7 Million
25,900 Added 27.35%
120,600 $71.2 Million
Q4 2021

Feb 14, 2022
SELL
$569.0 - $667.24 $8.88 Million - $10.4 Million
-15,600 Reduced 14.14%
94,700 $63.2 Million
Q1 2020

May 15, 2020
SELL
$255.3 - $340.05 $28.1 Million - $37.5 Million
-110,200 Reduced 49.98%
110,300 $31.3 Million
Q4 2019

Feb 14, 2020
SELL
$271.93 - $328.04 $35.7 Million - $43.1 Million
-131,400 Reduced 37.34%
220,500 $71.6 Million
Q3 2019

Nov 14, 2019
SELL
$268.46 - $305.43 $29.8 Million - $33.9 Million
-110,900 Reduced 23.96%
351,900 $102 Million
Q2 2019

Aug 14, 2019
BUY
$257.51 - $295.55 $3.99 Million - $4.58 Million
15,500 Added 3.47%
462,800 $136 Million
Q1 2019

May 15, 2019
BUY
$212.17 - $273.72 $2.08 Million - $2.68 Million
9,800 Added 2.24%
447,300 $122 Million
Q4 2018

Feb 14, 2019
SELL
$208.47 - $251.98 $48.1 Million - $58.1 Million
-230,500 Reduced 34.51%
437,500 $97.9 Million
Q3 2018

Nov 14, 2018
BUY
$205.57 - $244.32 $17.4 Million - $20.6 Million
84,500 Added 14.48%
668,000 $163 Million
Q2 2018

Aug 14, 2018
BUY
$203.14 - $219.53 $39.4 Million - $42.6 Million
194,100 Added 49.85%
583,500 $121 Million
Q4 2017

Feb 14, 2018
SELL
$182.03 - $200.37 $26.4 Million - $29 Million
-144,800 Reduced 27.11%
389,400 $73.9 Million
Q3 2017

Nov 14, 2017
BUY
$171.74 - $194.04 $91.7 Million - $104 Million
534,200
534,200 $101 Million

Others Institutions Holding TMO

# of Institutions
2,829
Shares Held
334M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email